Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Practice environmental safety in Style: Divulging Famous Electric Vehicle Brands - 2Striking American and European television Projects: A Survey
- 3Exploring the School Application Cycle: Understudy Bits of knowledge
- 4What is a Trump Gold Card? U.S. launches $1 million immigration visas
- 5Novo Nordisk gears up for December Ozempic launch in India, sources say
- Presenting Nintendo's New Pastel Satisfaction Con Tones for Switch Gamers: 3 Upscale Choices
- Fascinating Fishing Objections From Around The World
- EU Council president: Ukraine should receive binding guarantees
- U.K. blocks Kanye West from entering Britain to headline now canceled festival: What led to the ban
- South African army arrive in crime hotspots to help tackle gangs
- Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- Vote In favor of Your Favored Kind Of Tea
- Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- Ukrainian man arrested in Germany on suspicion of spying for Russia
